Latest McKesson News & Updates
See the latest news and media coverage for McKesson. We track all announcements, press releases, and industry mentions in real time, all in one place.
Diversified healthcare services and distribution company
mckesson.com- Headquarters
- Irving, United States
- Company type
- Public company
- Number of employees
- 20,000+
Last updated
Latest news about McKesson
In short: McKesson divested its Norwegian operations to exit Europe, announced a $1.25 billion deal for its surgical unit, and saw strong fiscal 2026 growth.
Company announcements
-
McKesson reports fiscal 2026 Q4 and full-year results
Revenues reached $96.3B in Q4 and $403.4B yearly. Adjusted EPS grew 16% in Q4 and 18% yearly. Fiscal 2027 guidance sets Adjusted EPS at $43.80-$44.60. Share repurchase program expanded.
-
McKesson signs agreement with Apollo for minority MMS interest
Apollo will invest $1.25 billion for about a 13% stake, valuing MMS near $13 billion. McKesson retains majority ownership and operating control; deal subject to customary approvals.
-
InspiroGene introduces Biologics in a Box
It streamlines CGT delivery with Biologics by McKesson, offering direct therapy delivery, operational control, and value chain alignment.
-
McKesson launches Biologics in a Box for CGT delivery
InspiroGene collaborates with Biologics by McKesson to co-locate cold-chain storage and pharmacy services, reducing handoffs, risks, and accelerating patient treatments.
Media coverage
-
McKesson anticipates fiscal 2027 adjusted EPS of $43.80-$44.60 while advancing medical-surgical separation
Q4 fiscal 2026 Management View "Earlier today, we reported a good fourth quarter that caps a year of strong performance," said (CEO & Director Brian...
-
McKesson: Fiscal Q4 Earnings Snapshot
IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Thursday reported fiscal fourth-quarter net income of $1.68 billion. On a per-share basis...
-
McKesson expects 2027 profit slightly above estimates on drug distribution strength
McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates on Thursday, as the U.S. drug distributor banks on strength in...
-
McKesson (NYSE:MCK) Misses Q1 CY2026 Revenue Estimates
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2026, ...
Track McKesson and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
McKesson competitors & trending companies
Browse news for competitors to McKesson and other trending companies.
Cencora
Cardinal Health
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze